NPI registry status
Active
2026 NPPES data Urology Physician NPI 1144278722 MD
Verify on CMS → David Cozzolino, MD
Urology Physician in Wilmington, Delaware.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 658 beneficiaries · Urology Physician avg: 1K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.1/100
▲ 3 pts above national avg 83.5 · Above neutral
Industry payments
$416.61
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
David Cozzolino, MD reported a CMS MIPS final score of 86.1/100 - above the 83.5 national average - and filed 2,107 Medicare Part D claims in 2024.
- 86.1/100
- MIPS score · +3 vs avg
- 2K
- Part D claims, 2024
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about David Cozzolino, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1144278722), first enumerated 05/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,107 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 86.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$416.61 in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1144278722 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1144278722
- ENUM-LEGACY 2006
- TAX-MID 14K Urology Physician
- MIPS-INLINE 86.1/100
- RX-MID 2,107
- BOOK-THIN 38 in Delaware
- PHOTO-FINISH Gennady Bratslavsky · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Cozzolino · this…
Cozzolino · this provider
86.1 MIPS pts
- J Trussell · hig…
J Trussell
86.1 MIPS pts
- Gennady Bratslav…
Gennady Bratslavsky
86.1 MIPS pts
- Timothy Byler · …
Timothy Byler
86.1 MIPS pts
- Oleg Shapiro · n…
Oleg Shapiro
86.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
David Cozzolino, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
86 ≥ 49th percentile 49% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where David Cozzolino, MD sits
This provider among urology physician peers
Across the 4,091 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, David Cozzolino, MD writes more Part D claims than 73% of them and scores higher on MIPS quality than 46% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one urology physician peer from a representative sample of 60; the gold marker is David Cozzolino, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
David Cozzolino, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Cozzolino, MD?
High performer (top quartile)Primary specialty
Urology Physician
Medicare Part D claims
2,107 56% vs specialty avg
MIPS final score
86.1/100 2.6 pts vs avg
Specialty distribution in Delaware
How Urology Physician compares to other specialties among Delaware providers
Medicare quality performance, MIPS
David Cozzolino, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 86.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1144278722 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
86.0563
Final Score
Measured-score avg: 83.5
65.1408
Quality
100
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Cozzolino, MD. Source: openpaymentsdata.cms.gov.
Total received
$417
Largest payer
Sumitomo Pharma America, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
David Cozzolino, MD - brand share 14.0%
Urology Physician average
14% brand-name claims vs 86% generic, on 2,107 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,107
Total Claims
$951K
Total Drug Cost
658
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,570.6
- Total Day Supply
- 123,672
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $896K
- Generic Drug Cost
- $55K
- Opioid Claims
- 14 (0.7% rate)
- Antibiotic Claims
- 489
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.18
- Gender Split
- 14% female / 86% male
- Age Distribution
- <65: 25, 65-74: 288, 75-84: 281, 85+: 64
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What David Cozzolino, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
702 claims
- Nitrofurantoin Mon… 190
Nitrofurantoin Mono-Macro
190 claims
- Cephalexin 169
Cephalexin
169 claims
- Finasteride 140
Finasteride
140 claims
- Alfuzosin Hcl Er 101
Alfuzosin Hcl Er
101 claims
- Myrbetriq 72
Myrbetriq
72 claims
- Oxybutynin Chlorid… 59
Oxybutynin Chloride Er
59 claims
- Cefpodoxime Proxetil 56
Cefpodoxime Proxetil
56 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 702 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 190 |
| Cephalexin | 169 |
| Finasteride | 140 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 101 |
| Myrbetriq Mirabegron | 72 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 59 |
| Cefpodoxime Proxetil | 56 |
| Dutasteride | 56 |
| Gemtesa Vibegron | 53 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How David Cozzolino, MD fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
David Cozzolino, MD's 2,107 claims are above the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Cozzolino, both outside Delaware so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (86.1 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as Cozzolino.
One of 38 Urology Physician providers enrolled in Delaware, 5 are shown here.
Dr. Jose Barriocanal
M.D.
Seaford, DE
Dr. Julia Barthold
MD
Wilmington, DE
Dr. Bruce Benge
MD
New Castle, DE
Dr. Robert Brown
M.D.
New Castle, DE
Dr. Christopher Caputo
M.D.
Lewes, DE
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is David Cozzolino, MD's specialty? ▼
David Cozzolino, MD specializes in Urology Physician and practices in Wilmington, Delaware. Credentials: MD.
How much does David Cozzolino, MD prescribe under Medicare Part D? ▼
In 2024, David Cozzolino, MD wrote 2,107 Medicare Part D claims totaling $951K in drug costs for 658 beneficiaries.
What is David Cozzolino, MD's Medicare quality score? ▼
David Cozzolino, MD has a CMS MIPS Final Score of 86.1/100 (Quality: 65.1, Cost: 100). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is David Cozzolino, MD located? ▼
David Cozzolino, MD is located at 2000 FOULK ROAD, Wilmington, DE, 19810. Phone: (302) 652-8990.
What is David Cozzolino, MD's NPI number? ▼
David Cozzolino, MD's National Provider Identifier (NPI) is 1144278722, issued on 05/05/2006.
Does David Cozzolino, MD prescribe more brand-name or generic drugs? ▼
David Cozzolino, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $896K in brand drug costs.
Does David Cozzolino, MD prescribe opioids? ▼
Yes, David Cozzolino, MD had 14 opioid claims in 2024 with an opioid prescribing rate of 0.7%.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does David Cozzolino, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, David Cozzolino, MD's most frequently prescribed drugs include Tamsulosin Hcl, Nitrofurantoin Mono-Macro, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Cozzolino, MD accept Medicare? ▼
David Cozzolino, MD appears in CMS Medicare data with 2,107 Part D claims and 658 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Cozzolino, MD's credentials? ▼
David Cozzolino, MD's NPI is 1144278722 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.